自报青霉素过敏及克林霉素给药或为种植体失败风险因素:系统评价、荟萃分析与脱标签方案
该系统评价与荟萃分析检索三个数据库,纳入4项研究,发现因自报青霉素过敏而接受克林霉素的患者种植体失败风险更高(OR=3.30,95%CI 2.58-4.22,P<.00001),平均累积失败比例11.0%(95%CI 3.5-22.0%),而接受阿莫西林者仅3.8%(95%CI 1.2-7.7%)。作者同时提出青霉素过敏脱标签方案。
要点
- 自报青霉素过敏而用克林霉素者种植体失败风险约为对照的3.30倍(OR=3.30,95%CI 2.58-4.22)。
- 克林霉素组平均累积失败比例11.0%(95%CI 3.5-22.0%),阿莫西林组3.8%(95%CI 1.2-7.7%)。
- 证据基于回顾性观察性研究,尚难判定青霉素过敏、克林霉素或两者共同导致该趋势。
核心结论
- 当前证据仍有限且基于回顾性观察性研究,难以确定青霉素过敏、克林霉素给药或两者共同作用导致所报告趋势。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Scopus和Web of Science三个数据库,从572条结果中纳入4项研究。
主要发现
- 固定效应荟萃分析显示,因自报青霉素过敏而接受克林霉素的患者失败种植体数更多。
- 这些患者发生种植体失败的可能性超过三倍(OR=3.30,95%CI 2.58-4.22,P<.00001)。
- 克林霉素组平均累积失败比例为11.0%(95%CI 3.5-22.0%),无需克林霉素而接受阿莫西林的患者为3.8%(95%CI 1.2-7.7%)。
关键数值与推荐
- 克林霉素组平均累积失败比例11.0%(95%CI 3.5-22.0%),阿莫西林组3.8%(95%CI 1.2-7.7%)。
- 种植体失败OR=3.30(95%CI 2.58-4.22,P<.00001)。
- 提出青霉素过敏脱标签方案。
临床怎么用
- 对自报青霉素过敏且需克林霉素替代的患者,应关注种植体失败风险升高的现有证据。
- 可参考文中提出的青霉素过敏脱标签方案处理自报青霉素过敏患者。
局限性
- 当前证据仍有限且基于回顾性观察性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Growing evidence is highlighting the inefficacy of clindamycin as an effective substitute to amoxicillin in patients self-reporting a penicillin allergy. The hypothesis is that implant failure is higher in these patients, when compared to patients receiving penicillin. To test this hypothesis, a systematic review and meta-analysis was undertaken and a protocol for delabeling penicillin allergic patients was presented. MATERIALS AND METHODS: A systematic review was undertaken by searching across three different databases, namely PubMed, Scopus and Web of Science. RESULTS: Out of 572 results, four studies were eligible to be included. Fixed-effects meta-analysis showed a higher number of failed implants in patients who were administered clindamycin, because of a self-reported allergy to penicillin. Results showed that these patients are over three times more likely (OR = 3.30, 95% C.I. 2.58-4.22, p-value < .00001) to undergo implant failure with an average cumulative proportion of 11.0% (95% C.I. 3.5-22.0%) versus 3.8% (95% C.I. 1.2-7.7%) of patients not requiring clindamycin and administered amoxicillin. A protocol for penicillin allergy delabeling is proposed. CONCLUSIONS: Current evidence is still limited and based on retrospective observational studies, it is difficult to state if penicillin allergy, clindamycin administration or a combination of both is responsible for the current trends and reported findings.
引用
- Edibam NR, Lorenzo-Pouso AI, Caponio VCA, et al. Self-reported allergy to penicillin and clindamycin administration may be risk factors for dental implant failure: A systematic review, meta-analysis and delabeling protocol. Clin Oral Implants Res. 2023. PMID: 37102260. doi:10.1111/clr.14073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。